Because passions should rule one’s life. Not diabetes!

Diabeloop partners with patients: Since its creation, Diabeloop has been involving people living with Type 1 or Type 2 diabetes and their relatives from the very first phases of development of its innovations, alongside engineers and doctors.

The creation of intuitive interfaces for the personalized solutions developed by Diabeloop are inspired by the requests of patients and their personal experiences, so that they can spend less time on their diabetes, and more on their passions!

The international launch of an independent young company

In November 2018, Diabeloop’s first medical device, DBLG1, was CE marked. We are working on commercializing, in Europe (France and Germany at first) and later in North America.

To support our international ambition and our Research and Development roadmap, we completed a Series B round of funding, setting a European fundraising record for therapeutic artificial intelligence.

Discover the company

Our latest news

11/21/2022

Interview with Alexandre: his role as Data Scientist, and his definition and views of data sciences

“If, thanks to Data Science, at least one person has...

11/15/2022

Launch of Diabeloop Talks – My passion rules my life. Not diabetes.

Diabeloop is launching the first series of Diabeloop Talks

11/10/2022

Joint interview with Fleur and Fanny, R&D Quality Specialists at Diabeloop

How they complement each other, their key challenges and their...

Reduce the heavy burden for people with diabetes

Diabeloop developed a self-learning algorithm that embeds therapeutic artificial intelligence, to automate Type 1 diabetes treatment. It is intended to relieve people affected by this chronic condition from having to make constant therapeutic decisions every day and night, and to allow them to live life without interruption.

Our products